divislab glp-1 novo nordisk relation A $60 billion industry just found its next growth lever. π With the expiry of a key patent on March 20, 2026, Indian pharma majors are launching generic weight-loss and diabetes drugs Novo Nordisk pens GLP-1 implant
Pay in 4 interest-free payments of $5.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Nov 17 - Nov 22












:max_bytes(150000):strip_icc()/alpha-lipoic-acid-88727-final-a73284168ec14df7a43f74d620dce23d.png)















